baber/WOPTO huggingface dataset:
Patent NZ-274737-A (NZ)
Title: Glass sheet bending; glass sheet is bent between a pair of deformable moulds, details of connector links between the moulds
Inventor: REUNAMAKI PAULI T
IPC: C03B27/044
Filed: 1994-10-05
Abstract: Glass sheet bending apparatus (20) including lower and upper deformable molds (22,44) having respective mold members (24,46) connected by associated linkages (26,48). An actuating mechanism (154) of the apparatus is constructed so as to move the linkages (26,48) to perform the bending which may be performed by moving the deformable molds (22,44) toward each other during the bending. <IMAGE>
Patent NZ-296892-A (NZ)
Title: Treatment to prevent dermatitis comprises administering an amount of a potassium-sparing diuretic
Inventor: WILLE JOHN J
IPC: A61K31/505
Filed: 1995-11-15
Abstract: Methods and devices for preventing an adverse reaction of the skin to the presence of a skin-sensitizing agent by administering an effective amount of a potassium-sparing diuretic.
Patent NZ-303144-A (NZ)
Title: A joint for concrete building elements comprising connecting pins inclined opposite to shearing forces relative to the the joint
Inventor: ARGAY IVAN
IPC: E04B9/18
Filed: 1997-03-26
Abstract: The timber forms a 30mm rebate (5) round the formwork for a concrete column (1) where it connects to a suspended slab (3) is holed to receive rows of short parallel steel bars (2) angled at about 45deg to the plane of the joint. When the formwork is struck, half the length of the bars (2) project from all the column faces. Alternatively, the rows of bars (2) may be mounted on a steel plate (7) by welding the bars centrally at 45deg in pre-drilled holes (8). The bar assembly is then concreted into the column and the slab poured against the projecting half of the bars.
Patent NZ-323103-A (NZ)
Title: A soft, bulky absorbent paper containing chemithermomechanical pulp
Inventor: WALLENIUS HANS
IPC: D21H11/14
Filed: 1996-11-21
Abstract: PCT No. PCT/SE96/01516 Sec. 371 Date May 21, 1998 Sec. 102(e) Date May 21, 1998 PCT Filed Nov. 21, 1996 PCT Pub. No. WO97/19198 PCT Pub. Date May 29, 1997Soft, bulky, absorbent paper containing at least 20 percent by weight of a high-temperature chemithermomechanical pulp (HT-CTMP), calculated on the total fibre weight. The paper also contains at least 10 percent by weight pulp that exhibits good strength properties, such as chemical pulp and/or recycled fibre pulp, and has a bulk of at least 5.5 cm3/g. The bulk, absorption and liquid-dispersion properties of the paper are enhanced by admixing HT-CTMP with the paper pulp.
Patent NZ-332283-A (NZ)
Title: Method and apparatus for making metallic iron
Inventor: NEGAMI TAKUYA
IPC: C21B13/10
Filed: 1997-03-13
Abstract: A method of making metallic iron is disclosed in which a compact 1, containing iron oxide such as iron ore or the like and a carbonaceous reductant such as coal or the like, is used as material, and the iron oxide is reduced through the application of heat, thereby making metallic iron. In the course of this reduction, a shell 1a composed of metallic iron is generated and grown on the surface of the compact, and slag aggregates inside the shell. This reduction continues until substantially no iron oxide is present within the metallic iron shell. Subsequently, heating is further performed to melt the metallic iron and slag. Molten metallic iron and molten slag Sg are separated one from the other, thereby obtaining metallic iron with a relatively high metallization ratio. Through the employment of an apparatus for making metallic iron of the present invention, the above-described method is efficiently carried out, and metallic iron having a high iron purity can be made continuously as well as productively not only from iron oxide having a high iron content but also from iron oxide having a relatively low iron content.
Patent NZ-332341-A (NZ)
Title: Quinoline carboxamides as TNF inhibitors and as PDE-IV inhibitors
Inventor: DYKE HAZEL JOAN
IPC: A61K31/47
Filed: 1997-05-20
Abstract: A compound of formula I or a pharmaceutically acceptable salt thereof is claimed wherein: X is CO or CS; R1 is OH, optionally halo-substituted alkoxy or thioalkyl; R2, R3 and R4 are independently H, R7, OR11, COR7, C(=NOR7)R7, alkyl-C(=NOR7)R7, halogen, CF3, alkyl-C(=NOH)R7, CN, CO2H, CO2R11, CONH2, CONHR7, CON(R7)2, NR9R10 or CONR12R13 wherein NR12R13 is a optionally substituted heterocyclic ring; R5 is H, optionally substituted aralkyl, heteroarylalkyl or heterocycloalkyl, S(O)mR11 or optionally substituted alkyl; R6 is optionally substituted aryl, heteroaryl, heterocycloalkyl, heterocyclo or heteroaralkyl and R7 and R9-R11 are as defined in the specification. A pharmaceutical composition containing a compound of formula I useful in the treatment of a disease state capable of being modulated by inhibition of phosphodiesterase IV or tumour necrosis factor is claimed.
Patent NZ-503841-A (NZ)
Title: Method and apparatus for high rate packet data transmission in cellular or radio network
Inventor: GROB MATTHEW
IPC: H04W40/16
Filed: 1998-11-03
Abstract: Packet data is transmitted at high speed from a base station to a mobile by first paging the mobile for a pending data transmission and measuring the C/I (signal-to-noise-and-interference ratio) of forward link signals from the base stations in the active set of the mobile.  A base station of the active set is selected based on a set of parameters including the measured C/I and identified to the mobile which sends a data request message to the selected base station.  The data packet portion is transmitted to the mobile from the selected base station at a data rate supportable by the mobile and in accordance with the data request message.  The measurements and selection is performed at each time slot until the data transmission is completed to maximize the data transmission rate.
Patent NZ-509521-A (NZ)
Title: Use of biogenic estrogen sulfamates for hormone replacement therapy
Inventor: ZIMMERMAN HOLGER
IPC: A61K31/565
Filed: 1999-05-13
Abstract: Described is the use of biogenic estrogen sulfamates for the production of pharmaceutical agents for oral, intermittent administration for hormone replacement therapy, whereby the individual administrations have an interval of 2 to 40 days.
Patent NZ-514053-A (NZ)
Title: Method and apparatus for treating dyslexia
Inventor: LAWSON ALISON MARIE
IPC: G09B17/00
Filed: 2000-03-09
Abstract: A method for treating Dyslexia in a patient comprising the step of employing techniques to achieve a stable fixation of both eyes. The method may comprise the step of employing techniques to strengthen the magnocellular visual pathways of the patient. In one embodiment, the method comprises utilising a series of visual image exercises provided so as to achieve the stable fixation and to strengthen the magnocellular visual pathways. The visual images can comprise one or more series of high frequency striations interposed with a visual work exercise exercising the patient mental faculties. The visual work exercise can include, for example, one of a puzzle, a drawing or a story. The visual work exercises are preferably of increasing mental complexity. In a further modification, the step can further comprise occluding one of the patients eyes during the visual image exercise and/or colour filtering the light transmitted to the patients eyes during the visual image exercise. Preferably a red filter is utilised.
Patent NZ-519183-A (NZ)
Title: Triazaspiro[5.5]undecane derivatives and pharmaceutical compositions comprising thereof, as an active ingredient
Inventor: HABASHITA HIROMU
IPC: C07D471/10
Filed: 2000-12-01
Abstract: Triazaspiro[5.5]undecane derivatives of formula (I), quaternary ammonium salts thereof, N-oxides thereof, nontoxic salts thereof, and drugs containing the same as the active ingredient are disclosed, wherein R1, R2, R3, R4 & R5 are as defined in the specification. Because of inhibiting the effects of chemokine/chemokine receptor, the compounds of formula (I) are useful in preventing and/or treating various inflammatory diseases, asthma, atopic dermatitis, urticaria, allergic diseases, nephritis, nephropathy, hepatitis, arthritis, rheumatoid arthritis, etc.
Patent NZ-520346-A (NZ)
Title: Use of MIA in immunotherapy
Inventor: NELISSEN ROBERT LOUIS HUBERT
IPC: A61K38/095
Filed: 2001-03-15
Abstract: Use of MIA (melanoma inhibiting activity) protein in the manufacture of a pharmaceutical preparation against inflammatory disease. Also disclosed are pharmaceutical compositions comprising an effective amount of a 9 amino acid fragment of MIA which has anti-inflammatory effects.
Patent NZ-521815-A (NZ)
Title: Endoventricular device for the treatment and correction of cardiomyopathies
Inventor: FERRAZZI PAOLO
IPC: A61F2/24
Filed: 2001-03-28
Abstract: A device that concerns the optimisation of the cardiac geometry in patients with heart failure. The device comprises one or more elastic elements in the radial direction towards the inside of the ventricle and plastic deformation in a direction that is transversal to the said ventricle, the element being equipped with means for attaching it to the internal wall of the ventricle.
Patent NZ-522594-A (NZ)
Title: Bicyclyl or heterobicyclylmethanesulfonylamino-substituted N-hydroxyformamides
Inventor: BEST DESMOND JOHN
IPC: A61K31/4155
Filed: 2001-05-21
Abstract: The application relates to compounds of formula (I) as shown below, where: - R is hydrogen, alkyl, alkenyl, alkynyl, aryl, heteroaryl, or heterocyclyl and - R1 is bicyclyl or heterobicyclyl. Compund (IA) is also disclosed where: - R is hydrogen, alkyl, alkenyl, alkynyl, aryl, heteroaryl, or heterocyclyl, and - R1 is bicyclyl or heterobicyclyl. The compounds disclosed can be used in the treatment or prophylaxis of disorders in which the overproduction of s-CD23 is implicated or conditions which are mediated by TNF. A process for the production of compounds described above is also disclosed.
Patent NZ-523316-A (NZ)
Title: Fatty acid analogues for the treatment of cancer
Inventor: BERGE ROLF
IPC: A61K/
Filed: 2001-07-13
Abstract: Use of known fatty acid analogues of formula R1-[xi-CH2]n-COOR--2 for the prevention and/or inhibition of primary and secondary metastatic neoplasms are disclosed, wherein R1, R2, n, i and xi are as defined in the specification.
Patent NZ-526782-A (NZ)
Title: Cannabinoid receptor ligands
Inventor: KOZLOWSKI JOSEPH A
IPC: C07D213/74
Filed: 2002-02-07
Abstract: Disclosed are compounds of formula (I), wherein: R1 is H, alkyl, halo-alkyl, cycloalkyl, cycloalkylNH-, arylalkyl, heterocycloalkyl, heteroaryl, N(R2)2, or NR2aryl, or optionally substituted aryl, R2 is independently selected from H and alkyl, R3 is H, alkyl, Cl, F, CF3, OCF2H, OCF3, OH or alkoxy, R4 is H, alkyl, alkoxy, cycloalkyl, alkenyl, aryl, benzyl, heteroaryl, heterocycloalkyl, arylNH-, heteroarylNH-, cycloalkylNH-, N(R2)2, or NR2aryl, the alkyl, alkoxy, cycloalkyl, alkenyl, phenyl or heteroaryl being optionally substituted, R5 is H or alkyl, R6 is H or alkyl, or R5 and R6 are taken together to form a carbonyl group, and the remaining substituents are defined herein. The compounds are used in the manufacture of medicaments to stimulate cannabinoid CB2 receptors in a mammal.
Patent NZ-530819-A (NZ)
Title: Extending the range of a hand-portable radio with short range of communication using on-board station receivers
Inventor: PENNANCE NICHOLAS
Filed: 2004-01-27
Abstract: A system and method for mobile radio communication is disclosed. The system includes (a) a network having one or more radio base stations and a central station, (b) an on-board radio station that has a relatively long range for communication with other stations, and (c) a portable radio station that has a relatively short range for communication with other stations. The on-board station receives messages from the portable station over a half duplex channel when the on-board station is within range of the network. When the portable station is out of range of the network, the portable station stores the messages, and forwards the messages to the network over a different radio channel.
Patent NZ-531575-A (NZ)
Title: Rotary lock and key
Inventor: PREDDEY BRIAN FRANCIS
IPC: E05B27/06
Filed: 2004-03-08
Abstract: A cylinder lock is provided. The lock includes a rotor assembly (17) having a combination post (12) as a core. The combination post (12) has combination holes arranged thereon which define the combination of the lock. The rotor assembly (17) includes locking bars having pins (15) directed radially towards the combination post (12). The locking bars are displaceable in an axial position by an appropriately coded key until each pin (15) is directed towards a respective combination hole. Turning the key causes the rotor assembly (17) to rotate. At various rotational positions, the locking bars are displaced radially causing the pins (15) to engage their respective combination holes. The combination post (12) can be provided with parallel combination holes. Furthermore, the combination post (12) can be removable in order to replace the combination post (12) with another post having different combination values, thereby changing the combination of the lock.
Patent NZ-531601-A (NZ)
Title: Multi-section boat sail
Inventor: PETRETTO GESUINO
IPC: B63H9/06
Filed: 2002-09-13
Abstract: A boat sail (2) comprising a first (4) and a second (6) sheet, having similar shape and dimensions, coupled each other in correspondence of the outer perimeter and by a plurality of transverse ribs (12) provided between the sheets and suitable to divide the sail into multi-sections (11). The sail is characterised in that it provides a valve (14) that can be opened and closed to allow the air to enter within the sail into the space between the first and second sheets, at least a retractor element (15) on each rib that can take two positions, respectively for the closure of the rib and for opening the same, in order to make the sail take a wing contour shape, and means (16) for opening and closing the retractors.
Patent NZ-532285-A (NZ)
Title: Novel beta-phenyl-alpha oxysubstituted propionic derivatives: process for its preparation and their use in the preparation of pharmaceutically important compounds
Inventor: BHUNIYA DEBNATH
IPC: C07D265/36
Filed: 2002-10-15
Abstract: Beta-phenyl-alpha-oxysubstituted propionic acid derivatives of the general formula (I); processes for the preparation of compounds of the formula (I) and their use in the preparation of compounds of formula (II) are disclosed, wherein the variables shown in formula (I) and formula (II) are as defined in the specification.
Patent NZ-535456-A (NZ)
Title: Modified release formulations of at least one form of tramadol for oral administration
Inventor: SETH PAWAN
IPC: A61K9/22
Filed: 2003-02-21
Abstract: A modified release pharamaceutical composition which comprises a tablet that contains a core which consists of at least one form of tramadol selected from the group consisting of tramadol, enantiomers, pharamaceutically acceptable salts and combination thereof. A polymeric control release coating substantially surrounds the core. The polymeric constituents and the amounts contained in the coating are selected so that the tablet exhibits a delayed release of at least one form of tramadol.
Patent NZ-538276-A (NZ)
Title: Flying insect trap incorporated in to the lid of a rubbish bin
Inventor: HARRIS MIKAEL IVAN
Filed: 2005-02-20
Abstract: An insect trap adapted to be incorporated into a lid of a rubbish bin, wherein the trap includes an entry port located in the lid and which communicates with a one way duct system beneath the lid, a compartment in communication with the one way duct adapted to receive flies that pass through the entry port and the one way duct system, means to retain dead insects within the compartment while the lid of the rubbish bin remains closed and to be discharged from the compartment into the rubbish bin when the lid is opened, means to introduce a poison into the compartment in a manner that insects that enter the compartment through the entry port and one way duct system will contact the poison.
Patent NZ-540542-A (NZ)
Title: Early determination of network support for mobile IP
Inventor: DYCK JEFFREY
IPC: H04L12/56
Filed: 2003-12-11
Abstract: A method for early determination of network support for Mobile IP in a wireless communication system is disclosed. A mobile node is in communication with a wireless network. A test is then performed for a disconnect condition where the disconnect condition is an early indication of network non-support for Mobile IP as identified by at least a requirement for authentication. Early indication relates to identification of the non-support for Mobile IP prior to or during network packet connection. If the disconnect condition is found, the mobile node disconnects from the wireless network. If the disconnect condition is not found, the mobile node stays connected to the wireless network.
Patent NZ-542670-A (NZ)
Title: N-alkyl-hydroxamic acid-isoindolyl compounds and their pharmaceutical uses
Inventor: MAN HON-WAH
IPC: A61K31/4245
Filed: 2004-03-12
Abstract: Disclosed is an N-alkyl-hydroxamic acid-isoindolyl compound of formula I wherein: Y is -C(O)-, -CH2-, -CH2C(O)- or -SO2-; and wherein the rest of the substituents are disclosed within the specification. Also disclosed is the use of the above compound in the preparation of a composition for inhibiting PDE4 in a mammal, for modulating the production of TNF-alpha in a mammal or for inhibiting MMP in a mammal.
Patent NZ-544996-A (NZ)
Title: Compression screw with combination single and double flights
Inventor: KELLER JOSEPH L
Filed: 2006-01-30
Abstract: A screw for a compression dewatering device comprising an elongated shaft having axially spaced apart first and second ends, a conveying section at the first end of the shaft, having a single helical screw flight rigidly projecting from the shaft, a flightless transition section axially adjacent the conveying section, and a dewatering section axially adjacent the transition section, having a double helical screw flight rigidly projecting from the shaft. Another embodiment is a compression screw having a perforated tubular dewatering wall intermediate the ends, followed by an imperforate spool wall at the discharge end. The screw includes a central shaft, a conveying section extending axially from the inlet end of the shaft, having a single helical screw flight rigidly projecting from the shaft, a flightless plug section extending axially from the discharge end of the shaft, within the spool wall, and a dewatering section adjacent the plug section, having a double helical screw flight rigidly projecting from the shaft. A flightless transition section is situated between the conveying section and the dewatering section. A gravity feed device is operatively associated with the inlet end for depositing bulk solids material through the feed opening onto the conveying screw, and a drive system is operatively connected to the inlet end of the screw for rotating the screw in the housing.
Patent NZ-547608-A (NZ)
Title: Method for producing titanium metal alloy and intermetallic powders
Inventor: ZHANG DELIANG
Filed: 2006-05-31
Abstract: Disclosed is a method of producing an alloy including the steps of: (a) pressing a milled metal/metal oxide composite powder producing a powder compact, and (b) inserting the powder compact in an open die or an extrusion die, and, characterised by the steps of: (c) applying pressure to the powder compact, and (d) heating the powder compact in the die to the required temperature such that exothermic reactions between the metal and metal oxide in the powder compact is ignited, become self propagating and lead to formation of a mixture of alloy liquid and oxide solid, and (e) continuing to apply pressure to separate phases. This method is particularly used for the production of titanium based alloy and intermetallic powders.
Patent NZ-548873-A (NZ)
Title: Stable amorphous forms of montelukast sodium
Inventor: ALNABARI MOHAMMED
IPC: C07D215/16
Filed: 2005-02-03
Abstract: Disclosed are a stable, non-hygroscopic, free-flowing, amorphous form of montelukast sodium having a bulk density greater than 0.10g/cm3 and a montelukast sodium lactose co-precipitate, processes for producing same and their use as methods of treatment.
Patent NZ-550089-A (NZ)
Title: Dispensing device
Inventor: LEVEY JOHN MCBRIEN
IPC: B65D85/72
Filed: 2005-03-09
Abstract: A one use dispenser for separately storing, dispensing and applying proportional amounts of two substances, such as epoxy resin and hardener, includes a flexible receptacle 4, 4' for each substance separated by a fold line 3, so that when the dispenser is folded the receptacles are superposed on each other and the rupturable outlets 7 which converge toward the fold line are superposed for dispensing and mixing the substances when the receptacles are squeezed. The respective receptacles include marks indicating where the thumb and forefinger of one hand of the squeezer should be positioned so that when the dispenser is folded and the receptacles squeezed together the receptacles are substantially completely evacuated through the respective outlets.
Patent NZ-556039-A (NZ)
Title: Digital beam engine with laser source pulsed by a rotary disc micro-shutter for sweeping or scanning
Inventor: DESAULNIERS JEAN-MARC
IPC: G02B5/09
Filed: 2005-12-01
Abstract: Disclosed is a digital beam engine for video projection. The engine includes a laser source (1) generating a light beam which is pulsed by a rotary disc micro-shutter (4). The engine, by successive reflection on an alignment of reflective microscopic facets distributed on digitally controlled optical rotary discs (5, 7), will generate horizontal and vertical beam sweeping or scanning.
Patent NZ-562406-A (NZ)
Title: Multivalent pneumococcal polysaccharide-protein conjugate composition
Inventor: HAUSDORFF WILLIAM P
IPC: A61K39/395
Filed: 2006-03-31
Abstract: An immunogenic composition having 13 distinct polysaccharide-protein conjugates and optionally, an aluminum-based adjuvant, is described. Each conjugate contains a capsular polysaccharide prepared from a different serotype of Streptococcus pneumoniae (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F) conjugated to a carrier protein. The immunogenic composition, formulated as a vaccine, increases coverage against pneumococcal disease in infants and young children globally, and provides coverage for serotypes 6A and 19A that is not dependent on the limitations of serogroup cross-protection.
Patent NZ-567056-A (NZ)
Title: Improved testosterone gel and method of use
Inventor: MALLADI RAMANA
IPC: A61K9/06
Filed: 2006-10-12
Abstract: Disclosed is a hydroalcoholic gel pharmaceutical composition comprising: i. from 1.50 percent to 1.70 percent (w/w) testosterone; ii. from 0.6 percent to 1.2 percent (w/w) isopropyl myristate; iii. from 60 percent to 80 percent (w/w) of an alcohol selected from the group consisting of ethanol and isopropanol; iv. a sufficient amount of a thickening agent to give the composition a viscosity in excess of 9000 cps, said thickening agent being formed by combining a precursor polyacrylic acid with a neutralizer in the course of forming the composition; and v. water. Also disclosed is the use of testosterone for manufacturing the composition.
Patent NZ-567709-A (NZ)
Title: Method for treating joint damage comprising adminstering a CD20 antibody
Inventor: TOTORITIS MARK
IPC: C07K16/28
Filed: 2006-11-14
Abstract: Disclosed is the use of rituximab in the preparation of a medicament for the treatment of joint damage in a subject with rheumatoid arthritis (RA), wherein (a) the subject has exhibited an inadequate response to one or more anti-tumor necrosis factor (TNF) inhibitors; (b) the subject received at least one prior course of treatment with rituximab, and (c) the treatment when administered, comprises administering at least one further course of treatment with rituximab, wherein the further course of treatment is administered at least 24 weeks after the start of the prior course of treatment with rituximab, and each course of treatment comprises administration of two 1000 mg intravenous doses 14 days apart.